BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8070834)

  • 1. Antitumor effect of cisplatin against murine ascites Dalton's lymphoma.
    Prasad SB; Giri A
    Indian J Exp Biol; 1994 Mar; 32(3):155-62. PubMed ID: 8070834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
    Prasad SB; Giri A; Arjun J
    Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and ascorbic acid-mediated ultrastructural and biochemical changes in Dalton's lymphoma cells in vivo.
    Prasad SB; Rosangkima G; Nicol BM
    Eur J Pharmacol; 2010 Oct; 645(1-3):47-54. PubMed ID: 20655303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biochemical changes in mitochondria after cisplatin treatment of Dalton's lymphoma-bearing mice.
    Prasad SB; Rosangkima G; Kharbangar A
    Mitochondrion; 2010 Jan; 10(1):38-45. PubMed ID: 19766736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-cell association in ascites Dalton's lymphoma and the effect of cisplatin in vivo.
    Prasad SB; Arjun J
    Anticancer Drugs; 1991 Feb; 2(1):57-62. PubMed ID: 1958853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma.
    Rosangkima G; Prasad SB
    Indian J Exp Biol; 2004 Oct; 42(10):981-8. PubMed ID: 15511001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
    Gupta V; Singh SM
    Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin- and dietary ascorbic acid-mediated changes in the mitochondria of Dalton's lymphoma-bearing mice.
    Martha KR; Rosangkima G; Amenla L; Rongpi T; Prasad SB
    Fundam Clin Pharmacol; 2013 Jun; 27(3):329-38. PubMed ID: 22211279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
    Ajith TA; Anu V; Riji T
    J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment.
    Nicol BM; Prasad SB
    Braz J Med Biol Res; 2002 May; 35(5):549-53. PubMed ID: 12011939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive reduction in poly-ADP-ribosylation of histone proteins during Dalton's lymphoma induced ascites tumorigenesis in mice.
    Jaylata Devi B; Sharan RN
    Cancer Lett; 2006 Jul; 238(1):135-41. PubMed ID: 16126336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoimmunotherapeutical studies on Dalton's lymphoma with cis-platin.
    Bahadur A
    Pol J Pharmacol Pharm; 1985; 37(4):463-8. PubMed ID: 4080643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of Abrus abrin-derived peptide fraction against Dalton's lymphoma ascites model.
    Bhutia SK; Mallick SK; Maiti S; Maiti TK
    Phytomedicine; 2009 Apr; 16(4):377-85. PubMed ID: 18706794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of L-asparaginase from Cylindrocarpon obtusisporum MB-10 and its effect on the immune system.
    Raha SK; Dey SK; Roy SK; Chaudhuri S; Chakrabarty SL
    Biochem Int; 1990 Sep; 21(6):1001-11. PubMed ID: 2080916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin.
    Khynriam D; Prasad SB
    Braz J Med Biol Res; 2003 Jan; 36(1):53-63. PubMed ID: 12532227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma.
    Christina AJ; Joseph DG; Packialakshmi M; Kothai R; Robert SJ; Chidambaranathan N; Ramasamy M
    J Ethnopharmacol; 2004 Aug; 93(2-3):359-61. PubMed ID: 15234777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phyllanthus amarus inhibits cell growth and induces apoptosis in Dalton's lymphoma ascites cells through activation of caspase-3 and downregulation of Bcl-2.
    Harikumar KB; Kuttan G; Kuttan R
    Integr Cancer Ther; 2009 Jun; 8(2):190-4. PubMed ID: 19223368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model.
    Ramachandran S; Mandal M
    Biomed Pharmacother; 2011 Oct; 65(7):461-6. PubMed ID: 22000294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.